Innopeutics Corporation
2 clinical trials · Sponsor
◉ Watch Innopeutics Corporation
| Record | Firm | Date |
|---|---|---|
| Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients (NCT07371338) | Innopeutics Corporation | 2026-05-30 |
| A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product. (NCT07629115) | Innopeutics Corporation | 2026-05-29 |
Track Innopeutics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.